首页> 外国专利> EPIGENETIC MARKERS OF COLORECTAL CANCERS AND DIAGNOSTIC METHODS USING THE SAME

EPIGENETIC MARKERS OF COLORECTAL CANCERS AND DIAGNOSTIC METHODS USING THE SAME

机译:大肠癌的流行病标记和使用相同方法的诊断方法

摘要

To provide methods of screening for the onset of a large intestine neoplasm or for predisposition to onset of large intestine neoplasm in individuals.SOLUTION: The invention is directed to a nucleic acid molecule of which changes in DNA methylation levels are indicative of the onset and/or progression of large intestine neoplasms such as adenoma or adenocarcinoma. The DNA methylation status is usefully applied to diagnosis and/or monitoring of colorectal neoplasms such as colorectal adenocarcinoma but not limited thereto. Thus, a related aspect is directed to a method of screening for the onset, predisposition to the onset and/or progression of a neoplasm by screening modulation of the DNA methylation with one or a plurality of nucleic acid molecules.SELECTED DRAWING: None
机译:提供筛选个体中大肠肿瘤发作或易患大肠肿瘤的方法。解决方案:本发明涉及核酸分子,其DNA甲基化水平的改变指示该疾病的发生和/或大肠肿瘤(例如腺瘤或腺癌)的进展。 DNA甲基化状态可用于诊断和/或监测大肠肿瘤,例如大肠腺癌,但不限于此。因此,一个相关方面涉及通过筛选一个或多个核酸分子对DNA甲基化的调节来筛选肿瘤的发作,易感性和/或进展的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号